These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3514653)

  • 1. Failure to detect the "dawn phenomenon" in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion.
    Mauras N; Rogol AD; Clarke WL
    J Clin Endocrinol Metab; 1986 May; 62(5):975-9. PubMed ID: 3514653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dawn phenomenon does not occur in normal elderly subjects.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1986 Aug; 63(2):292-6. PubMed ID: 3522617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.
    Carroll MF; Hardy KJ; Burge MR; Schade DS
    Diabetes Technol Ther; 2002; 4(5):595-605. PubMed ID: 12450440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.
    Edge JA; Matthews DR; Dunger DB
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):729-37. PubMed ID: 2096008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of the dawn phenomenon in normal subjects.
    Simon C; Brandenberger G; Follenius M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):203-5. PubMed ID: 3288651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
    Bolli GB; Perriello G
    Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.
    Trümper BG; Reschke K; Molling J
    Horm Metab Res; 1995 Mar; 27(3):141-7. PubMed ID: 7607604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daytime pulsatile growth hormone secretion during childhood and adolescence.
    Miller JD; Tannenbaum GS; Colle E; Guyda HJ
    J Clin Endocrinol Metab; 1982 Nov; 55(5):989-94. PubMed ID: 6749884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive injections of growth hormone releasing hormone (GHRH1-44) to normal volunteers and patients with growth hormone deficiency.
    Hümmelink R; Sippell WG
    Horm Metab Res; 1990 Feb; 22(2):101-8. PubMed ID: 2182500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a dawn phenomenon in normal human volunteers.
    Bolli GB; De Feo P; De Cosmo S; Perriello G; Ventura MM; Calcinaro F; Lolli C; Campbell P; Brunetti P; Gerich JE
    Diabetes; 1984 Dec; 33(12):1150-3. PubMed ID: 6389230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
    Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1990 Jan; 33(1):52-9. PubMed ID: 2406181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.
    Beaufrère B; Beylot M; Metz C; Ruitton A; François R; Riou JP; Mornex R
    Diabetologia; 1988 Aug; 31(8):607-11. PubMed ID: 3065115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity.
    Heptulla R; Smitten A; Teague B; Tamborlane WV; Ma YZ; Caprio S
    J Clin Endocrinol Metab; 2001 Jan; 86(1):90-6. PubMed ID: 11231983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of the dawn glucose rise in nondiabetic men compared by age.
    Rosenthal MJ; Argoud GM
    J Gerontol; 1989 Mar; 44(2):M57-61. PubMed ID: 2646356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity.
    Van Cauter EV; Polonsky KS; Blackman JD; Roland D; Sturis J; Byrne MM; Scheen AJ
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1797-805. PubMed ID: 7989487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultradian growth hormone rhythm in the rat: effects of feeding, hyperglycemia, and insulin-induced hypoglycemia.
    Tannenbaum GS; Martin JB; Colle E
    Endocrinology; 1976 Sep; 99(3):720-7. PubMed ID: 954665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.